Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

INTRODUCTION: Diabetic macular edema (DME) threatens daily life activities such as reading and driving and reduces the patients’ quality-of-life. Recently, anti-vascular endothelial growth factor (VEGF) agents have become a first-line therapy in DME. However, therapy with anti-VEGF agents has severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishibashi, Ryoichi, Takatsuna, Yoko, Koshizaka, Masaya, Tatsumi, Tomoaki, Takahashi, Sho, Nagashima, Kengo, Asaumi, Noriko, Arai, Miyuki, Shimada, Fumio, Tachibana, Kaori, Watanabe, Yoshihiro, Ishikawa, Ko, Hoshino, Akiko, Yamamoto, Kyohei, Kubota-Taniai, Mariko, Mayama, Takafumi, Yamamoto, Shuichi, Yokote, Koutaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376811/
https://www.ncbi.nlm.nih.gov/pubmed/32542431
http://dx.doi.org/10.1007/s13300-020-00854-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376811/
https://www.ncbi.nlm.nih.gov/pubmed/32542431
http://dx.doi.org/10.1007/s13300-020-00854-6

Ejemplares similares